ACVR2A: Difference between revisions

ACVR2A
Available structures
PDB	Ortholog search: PDBe RCSB
List of PDB id codes
	3Q4T, 3SOC, 4ASX
Identifiers
Aliases	ACVR2A, ACTRII, ACVR2, activin A receptor type 2A
External IDs	OMIM: 102581; MGI: 102806; HomoloGene: 20391; GeneCards: ACVR2A; OMA:ACVR2A - orthologs
Gene location (Human)
Chr.	Chromosome 2 (human)
End	147,930,826 bp
Gene location (Mouse)
Chr.	Chromosome 2 (mouse)
End	48,793,281 bp
RNA expression pattern
	Top expressed in
	buccal mucosa cell; ; hair follicle; ; oocyte; ; skin of thigh; ; testicle; ; skin of abdomen; ; lactiferous duct; ; ganglionic eminence; ; tendon; ; Achilles tendon;
	Top expressed in
	trigeminal ganglion; ; olfactory tubercle; ; subiculum; ; anterior amygdaloid area; ; medial ganglionic eminence; ; epithelium of lens; ; triceps brachii muscle; ; tail of embryo; ; genital tubercle; ; nucleus accumbens;
	More reference expression data
	n/a
Gene ontology
Molecular function	transferase activity; nucleotide binding; protein kinase activity; PDZ domain binding; growth factor binding; coreceptor activity; activin binding; metal ion binding; kinase activity; protein self-association; protein serine/threonine kinase activity; transmembrane receptor protein serine/threonine kinase activity; inhibin binding; protein binding; activin-activated receptor activity; ATP binding; BMP receptor activity; transforming growth factor beta-activated receptor activity; transforming growth factor beta receptor activity, type II; type I transforming growth factor beta receptor binding; SMAD binding;
Cellular component	cytoplasm; integral component of membrane; inhibin-betaglycan-ActRII complex; membrane; receptor complex; plasma membrane; integral component of plasma membrane; cell surface; activin receptor complex;
Biological process	positive regulation of protein phosphorylation; male gonad development; ejaculation; positive regulation of erythrocyte differentiation; positive regulation of bone mineralization; phosphorylation; positive regulation of pathway-restricted SMAD protein phosphorylation; gastrulation with mouth forming second; penile erection; regulation of nitric-oxide synthase activity; cellular response to BMP stimulus; Sertoli cell proliferation; BMP signaling pathway; embryonic skeletal system development; regulation of BMP signaling pathway; protein phosphorylation; determination of left/right symmetry; transmembrane receptor protein serine/threonine kinase signaling pathway; positive regulation of activin receptor signaling pathway; positive regulation of osteoblast differentiation; regulation of signal transduction; spermatogenesis; mesoderm development; anterior/posterior pattern specification; positive regulation of transcription by RNA polymerase II; activin receptor signaling pathway; transforming growth factor beta receptor signaling pathway; pattern specification process;
	Sources:Amigo / QuickGO
Orthologs
	92
	11480
	ENSG00000121989
	ENSMUSG00000052155
	P27037
	P27038
	NM_001278579; NM_001278580; NM_001616
	NM_007396
	NP_001265508; NP_001265509; NP_001607
	NP_031422
	Wikidata
View/Edit Human	View/Edit Mouse

Browse history interactively

← Previous edit

Content deleted Content added

VisualWikitext

Inline

Latest revision as of 20:41, 13 August 2023

Activin receptor type-2A is a protein that in humans is encoded by the ACVR2A gene.^[5]^[6]^[7] ACVR2A is an activin type 2 receptor.

Function

This gene encodes activin A type II receptor. Activins are dimeric growth and differentiation factors which belong to the transforming growth factor-beta (TGF-beta) superfamily of structurally related signaling proteins. Activins signal through a heteromeric complex of receptor serine kinases which include at least two type I (I and IB) and two type II (II and IIB) receptors. These receptors are all transmembrane proteins, composed of a ligand-binding extracellular domain with cysteine-rich region, a transmembrane domain, and a cytoplasmic domain with predicted serine/threonine specificity. Type I receptors are essential for signaling; and type II receptors are required for binding ligands and for expression of type I receptors. Type I and II receptors form a stable complex after ligand binding, resulting in phosphorylation of type I receptors by type II receptors. Type II receptors are considered to be constitutively active kinases.^[7]

Interactions

ACVR2A has been shown to interact with:

References

^ ^a ^b ^c GRCh38: Ensembl release 89: ENSG00000121989 – Ensembl, May 2017
^ ^a ^b ^c GRCm38: Ensembl release 89: ENSMUSG00000052155 – Ensembl, May 2017
^ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
^ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
^ Donaldson CJ, Mathews LS, Vale WW (May 1992). "Molecular cloning and binding properties of the human type II activin receptor". Biochem. Biophys. Res. Commun. 184 (1): 310–6. doi:10.1016/0006-291X(92)91194-U. PMID 1314589.
^ Bondestam J, Horelli-Kuitunen N, Hildén K, Ritvos O, Aaltonen J (April 2000). "Assignment of ACVR2 and ACVR2B the human activin receptor type II and IIB genes to chromosome bands 2q22.2-->q23.3 and 3p22 and the human follistatin gene (FST) to chromosome 5q11.2 by FISH". Cytogenet. Cell Genet. 87 (3–4): 219–20. doi:10.1159/000015429. PMID 10702675. S2CID 36135054.
^ ^a ^b "Entrez Gene: ACVR2A activin A receptor, type IIA".
^ Lebrun JJ, Takabe K, Chen Y, Vale W (January 1999). "Roles of pathway-specific and inhibitory Smads in activin receptor signaling". Mol. Endocrinol. 13 (1): 15–23. doi:10.1210/mend.13.1.0218. PMID 9892009. S2CID 26825706.
^ De Winter JP, De Vries CJ, Van Achterberg TA, Ameerun RF, Feijen A, Sugino H, De Waele P, Huylebroeck D, Verschueren K, Van Den Eijden-Van Raaij AJ (May 1996). "Truncated activin type II receptors inhibit bioactivity by the formation of heteromeric complexes with activin type I. receptors". Exp. Cell Res. 224 (2): 323–34. doi:10.1006/excr.1996.0142. PMID 8612709.
^ Lewis KA, Gray PC, Blount AL, MacConell LA, Wiater E, Bilezikjian LM, Vale W (March 2000). "Betaglycan binds inhibin and can mediate functional antagonism of activin signalling". Nature. 404 (6776): 411–4. Bibcode:2000Natur.404..411L. doi:10.1038/35006129. PMID 10746731. S2CID 4393629.
^ Martens JW, de Winter JP, Timmerman MA, McLuskey A, van Schaik RH, Themmen AP, de Jong FH (July 1997). "Inhibin interferes with activin signaling at the level of the activin receptor complex in Chinese hamster ovary cells". Endocrinology. 138 (7): 2928–36. doi:10.1210/endo.138.7.5250. PMID 9202237.
^ Tsuchida K, Nakatani M, Matsuzaki T, Yamakawa N, Liu Z, Bao Y, Arai KY, Murakami T, Takehara Y, Kurisaki A, Sugino H (October 2004). "Novel factors in regulation of activin signaling". Mol. Cell. Endocrinol. 225 (1–2): 1–8. doi:10.1016/j.mce.2004.02.006. PMID 15451561. S2CID 34666659.
^ Matsuzaki T, Hanai S, Kishi H, Liu Z, Bao Y, Kikuchi A, Tsuchida K, Sugino H (May 2002). "Regulation of endocytosis of activin type II receptors by a novel PDZ protein through Ral/Ral-binding protein 1-dependent pathway". J. Biol. Chem. 277 (21): 19008–18. doi:10.1074/jbc.M112472200. PMID 11882656.

External links

Human ACVR2A genome location and ACVR2A gene details page in the UCSC Genome Browser.

Welt CK (2002). "The physiology and pathophysiology of inhibin, activin and follistatin in female reproduction". Curr. Opin. Obstet. Gynecol. 14 (3): 317–23. doi:10.1097/00001703-200206000-00012. PMID 12032389. S2CID 44327401.
Matzuk MM, Bradley A (1992). "Cloning of the human activin receptor cDNA reveals high evolutionary conservation". Biochim. Biophys. Acta. 1130 (1): 105–8. doi:10.1016/0167-4781(92)90472-C. PMID 1311955.
Mathews LS, Vale WW (1991). "Expression cloning of an activin receptor, a predicted transmembrane serine kinase". Cell. 65 (6): 973–82. doi:10.1016/0092-8674(91)90549-E. PMID 1646080. S2CID 36407277.
Xu J, McKeehan K, Matsuzaki K, McKeehan WL (1995). "Inhibin antagonizes inhibition of liver cell growth by activin by a dominant-negative mechanism". J. Biol. Chem. 270 (11): 6308–13. doi:10.1074/jbc.270.11.6308. PMID 7890768.
Attisano L, Cárcamo J, Ventura F, Weis FM, Massagué J, Wrana JL (1993). "Identification of human activin and TGF beta type I receptors that form heteromeric kinase complexes with type II receptors". Cell. 75 (4): 671–80. doi:10.1016/0092-8674(93)90488-C. PMID 8242742. S2CID 25408172.
Peng C, Huang TH, Jeung EB, Donaldson CJ, Vale WW, Leung PC (1993). "Expression of the type II activin receptor gene in the human placenta". Endocrinology. 133 (6): 3046–9. doi:10.1210/endo.133.6.8243335. PMID 8243335.
De Winter JP, De Vries CJ, Van Achterberg TA, Ameerun RF, Feijen A, Sugino H, De Waele P, Huylebroeck D, Verschueren K, Van Den Eijden-Van Raaij AJ (1996). "Truncated activin type II receptors inhibit bioactivity by the formation of heteromeric complexes with activin type I. receptors". Exp. Cell Res. 224 (2): 323–34. doi:10.1006/excr.1996.0142. PMID 8612709.
Attisano L, Wrana JL, Montalvo E, Massagué J (1996). "Activation of signalling by the activin receptor complex". Mol. Cell. Biol. 16 (3): 1066–73. doi:10.1128/mcb.16.3.1066. PMC 231089. PMID 8622651.
Liu QY, Niranjan B, Gomes P, Gomm JJ, Davies D, Coombes RC, Buluwela L (1996). "Inhibitory effects of activin on the growth and morpholgenesis of primary and transformed mammary epithelial cells". Cancer Res. 56 (5): 1155–63. PMID 8640777.
Nishitoh H, Ichijo H, Kimura M, Matsumoto T, Makishima F, Yamaguchi A, Yamashita H, Enomoto S, Miyazono K (1996). "Identification of type I and type II serine/threonine kinase receptors for growth/differentiation factor-5". J. Biol. Chem. 271 (35): 21345–52. doi:10.1074/jbc.271.35.21345. PMID 8702914.
Lebrun JJ, Vale WW (1997). "Activin and inhibin have antagonistic effects on ligand-dependent heteromerization of the type I and type II activin receptors and human erythroid differentiation". Mol. Cell. Biol. 17 (3): 1682–91. doi:10.1128/mcb.17.3.1682. PMC 231893. PMID 9032295.
Macías-Silva M, Hoodless PA, Tang SJ, Buchwald M, Wrana JL (1998). "Specific activation of Smad1 signaling pathways by the BMP7 type I receptor, ALK2". J. Biol. Chem. 273 (40): 25628–36. doi:10.1074/jbc.273.40.25628. PMID 9748228.
Barbara NP, Wrana JL, Letarte M (1999). "Endoglin is an accessory protein that interacts with the signaling receptor complex of multiple members of the transforming growth factor-beta superfamily". J. Biol. Chem. 274 (2): 584–94. doi:10.1074/jbc.274.2.584. PMID 9872992.
Lux A, Attisano L, Marchuk DA (1999). "Assignment of transforming growth factor beta1 and beta3 and a third new ligand to the type I receptor ALK-1". J. Biol. Chem. 274 (15): 9984–92. doi:10.1074/jbc.274.15.9984. PMID 10187774.
D'Abronzo FH, Swearingen B, Klibanski A, Alexander JM (1999). "Mutational analysis of activin/transforming growth factor-beta type I and type II receptor kinases in human pituitary tumors". J. Clin. Endocrinol. Metab. 84 (5): 1716–21. doi:10.1210/jcem.84.5.5704. PMID 10323406.
Ebisawa T, Tada K, Kitajima I, Tojo K, Sampath TK, Kawabata M, Miyazono K, Imamura T (1999). "Characterization of bone morphogenetic protein-6 signaling pathways in osteoblast differentiation". J. Cell Sci. 112 (20): 3519–27. doi:10.1242/jcs.112.20.3519. PMID 10504300.
van Schaik RH, Wierikx CD, Timmerman MA, Oomen MH, van Weerden WM, van der Kwast TH, van Steenbrugge GJ, de Jong FH (2000). "Variations in activin receptor, inhibin/activin subunit and follistatin mRNAs in human prostate tumour tissues". Br. J. Cancer. 82 (1): 112–7. doi:10.1054/bjoc.1999.0886. PMC 2363208. PMID 10638976.
Shoji H, Tsuchida K, Kishi H, Yamakawa N, Matsuzaki T, Liu Z, Nakamura T, Sugino H (2000). "Identification and characterization of a PDZ protein that interacts with activin type II receptors". J. Biol. Chem. 275 (8): 5485–92. doi:10.1074/jbc.275.8.5485. PMID 10681527.

[refGRCh38Ensembl-1] GRCh38: Ensembl release 89: ENSG00000121989 – Ensembl, May 2017

[refGRCm38Ensembl-2] GRCm38: Ensembl release 89: ENSMUSG00000052155 – Ensembl, May 2017

[3] "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.

[4] "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.

[pmid1314589-5] Donaldson CJ, Mathews LS, Vale WW (May 1992). "Molecular cloning and binding properties of the human type II activin receptor". Biochem. Biophys. Res. Commun. 184 (1): 310–6. doi:10.1016/0006-291X(92)91194-U. PMID 1314589.

[pmid10702675-6] Bondestam J, Horelli-Kuitunen N, Hildén K, Ritvos O, Aaltonen J (April 2000). "Assignment of ACVR2 and ACVR2B the human activin receptor type II and IIB genes to chromosome bands 2q22.2-->q23.3 and 3p22 and the human follistatin gene (FST) to chromosome 5q11.2 by FISH". Cytogenet. Cell Genet. 87 (3–4): 219–20. doi:10.1159/000015429. PMID 10702675. S2CID 36135054.

[entrez-7] "Entrez Gene: ACVR2A activin A receptor, type IIA".

[pmid9892009-8] Lebrun JJ, Takabe K, Chen Y, Vale W (January 1999). "Roles of pathway-specific and inhibitory Smads in activin receptor signaling". Mol. Endocrinol. 13 (1): 15–23. doi:10.1210/mend.13.1.0218. PMID 9892009. S2CID 26825706.

[pmid8612709-9] De Winter JP, De Vries CJ, Van Achterberg TA, Ameerun RF, Feijen A, Sugino H, De Waele P, Huylebroeck D, Verschueren K, Van Den Eijden-Van Raaij AJ (May 1996). "Truncated activin type II receptors inhibit bioactivity by the formation of heteromeric complexes with activin type I. receptors". Exp. Cell Res. 224 (2): 323–34. doi:10.1006/excr.1996.0142. PMID 8612709.

[pmid10746731-10] Lewis KA, Gray PC, Blount AL, MacConell LA, Wiater E, Bilezikjian LM, Vale W (March 2000). "Betaglycan binds inhibin and can mediate functional antagonism of activin signalling". Nature. 404 (6776): 411–4. Bibcode:2000Natur.404..411L. doi:10.1038/35006129. PMID 10746731. S2CID 4393629.

[pmid9202237-11] Martens JW, de Winter JP, Timmerman MA, McLuskey A, van Schaik RH, Themmen AP, de Jong FH (July 1997). "Inhibin interferes with activin signaling at the level of the activin receptor complex in Chinese hamster ovary cells". Endocrinology. 138 (7): 2928–36. doi:10.1210/endo.138.7.5250. PMID 9202237.

[pmid15451561-12] Tsuchida K, Nakatani M, Matsuzaki T, Yamakawa N, Liu Z, Bao Y, Arai KY, Murakami T, Takehara Y, Kurisaki A, Sugino H (October 2004). "Novel factors in regulation of activin signaling". Mol. Cell. Endocrinol. 225 (1–2): 1–8. doi:10.1016/j.mce.2004.02.006. PMID 15451561. S2CID 34666659.

[pmid11882656-13] Matsuzaki T, Hanai S, Kishi H, Liu Z, Bao Y, Kikuchi A, Tsuchida K, Sugino H (May 2002). "Regulation of endocytosis of activin type II receptors by a novel PDZ protein through Ral/Ral-binding protein 1-dependent pathway". J. Biol. Chem. 277 (21): 19008–18. doi:10.1074/jbc.M112472200. PMID 11882656.

[1]

[2]

[3]

[4]

[5]

[6]

[7]

[8]

[9]

[10]

[11]

[12]

[13]

@@ Line 1: / Line 1: @@
+{{Short description|Protein-coding gene in the species Homo sapiens}}
-{{PBB|geneid=92}}
+{{Infobox_gene}}
-{{Protbox
-  |Name = Activin receptor type-2A
+'''Activin receptor type-2A''' is a [[protein]] that in humans is encoded by the ''ACVR2A'' [[gene]].<ref name="pmid1314589">{{cite journal | vauthors = Donaldson CJ, Mathews LS, Vale WW | title = Molecular cloning and binding properties of the human type II activin receptor | journal = Biochem. Biophys. Res. Commun. | volume = 184 | issue = 1 | pages = 310–6  | date = May 1992 | pmid = 1314589 | doi = 10.1016/0006-291X(92)91194-U }}</ref><ref name="pmid10702675">{{cite journal | vauthors = Bondestam J, Horelli-Kuitunen N, Hildén K, Ritvos O, Aaltonen J | title = Assignment of ACVR2 and ACVR2B the human activin receptor type II and IIB genes to chromosome bands 2q22.2-->q23.3 and 3p22 and the human follistatin gene (FST) to chromosome 5q11.2 by FISH | journal = Cytogenet. Cell Genet. | volume = 87 | issue = 3–4 | pages = 219–20 | date = April 2000 | pmid = 10702675 | doi = 10.1159/000015429 | s2cid = 36135054 }}</ref><ref name="entrez">{{cite web | title = Entrez Gene: ACVR2A activin A receptor, type IIA| url = https://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=92}}</ref>
-  |Domains=  [[TS domain]], [[S/T domain]]
-  |Taxa = ''[[Homo sapiens]]''; homologs: many [[metazoan]] [[phylum (biology)|phyla]]
-  |Cofactors=[[Magnesium]] or [[manganese]]
-}}
-'''Activin A receptor, type IIA''', also known as '''ACVR2A''', is a human [[gene]].<ref name="entrez">{{cite web | title = Entrez Gene: ACVR2A activin A receptor, type IIA| url = http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=92| accessdate = }}</ref>
 ACVR2A is an [[activin type 2 receptor]].
-<!-- The PBB_Summary template is automatically maintained by Protein Box Bot.  See Template:PBB_Controls to Stop updates. -->
+== Function ==
-{{PBB_Summary
-| section_title =
-| summary_text = This gene encodes activin A type II receptor. Activins are dimeric growth and differentiation factors which belong to the transforming growth factor-beta (TGF-beta) superfamily of structurally related signaling proteins. Activins signal through a heteromeric complex of receptor serine kinases which include at least two type I (I and IB) and two type II (II and IIB) receptors. These receptors are all transmembrane proteins, composed of a ligand-binding extracellular domain with cysteine-rich region, a transmembrane domain, and a cytoplasmic domain with predicted serine/threonine specificity. Type I receptors are essential for signaling; and type II receptors are required for binding ligands and for expression of type I receptors. Type I and II receptors form a stable complex after ligand binding, resulting in phosphorylation of type I receptors by type II receptors. Type II receptors are considered to be constitutively active kinases.<ref name="entrez">{{cite web | title = Entrez Gene: ACVR2A activin A receptor, type IIA| url = http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=92| accessdate = }}</ref>
+This gene encodes activin A type II receptor. Activins are dimeric growth and differentiation factors which belong to the [[transforming growth factor-beta]] (TGF-beta) superfamily of structurally related signaling proteins. Activins signal through a heteromeric complex of [[receptor protein serine/threonine kinase|receptor serine kinases]] which include at least two type I (I and IB) and two type II (II and IIB) receptors. These receptors are all transmembrane proteins, composed of a ligand-binding extracellular domain with [[cysteine]]-rich region, a [[transmembrane domain]], and a [[cytoplasmic]] domain with predicted serine/threonine specificity. Type I receptors are essential for signaling; and type II receptors are required for binding ligands and for expression of type I receptors. Type I and II receptors form a stable complex after ligand binding, resulting in [[phosphorylation]] of type I receptors by type II receptors. Type II receptors are considered to be constitutively active kinases.<ref name="entrez"/>
+== Interactions ==
-}}
+ACVR2A has been shown to [[Protein-protein interaction|interact]] with:
-==References==
+* [[ACVR1B]],<ref name = pmid9892009>{{cite journal | vauthors = Lebrun JJ, Takabe K, Chen Y, Vale W | title = Roles of pathway-specific and inhibitory Smads in activin receptor signaling | journal = Mol. Endocrinol. | volume = 13 | issue = 1 | pages = 15–23  | date = January 1999 | pmid = 9892009 | doi = 10.1210/mend.13.1.0218 | s2cid = 26825706 | doi-access = free }}</ref><ref name = pmid8612709>{{cite journal | vauthors = De Winter JP, De Vries CJ, Van Achterberg TA, Ameerun RF, Feijen A, Sugino H, De Waele P, Huylebroeck D, Verschueren K, Van Den Eijden-Van Raaij AJ | title = Truncated activin type II receptors inhibit bioactivity by the formation of heteromeric complexes with activin type I. receptors | journal = Exp. Cell Res. | volume = 224 | issue = 2 | pages = 323–34  | date = May 1996 | pmid = 8612709 | doi = 10.1006/excr.1996.0142 }}</ref>
+* [[INHBA]],<ref name = pmid10746731>{{cite journal | vauthors = Lewis KA, Gray PC, Blount AL, MacConell LA, Wiater E, Bilezikjian LM, Vale W | title = Betaglycan binds inhibin and can mediate functional antagonism of activin signalling | journal = Nature | volume = 404 | issue = 6776 | pages = 411–4  | date = March 2000 | pmid = 10746731 | doi = 10.1038/35006129 | bibcode = 2000Natur.404..411L | s2cid = 4393629 }}</ref><ref name = pmid9202237>{{cite journal | vauthors = Martens JW, de Winter JP, Timmerman MA, McLuskey A, van Schaik RH, Themmen AP, de Jong FH | title = Inhibin interferes with activin signaling at the level of the activin receptor complex in Chinese hamster ovary cells | journal = Endocrinology | volume = 138 | issue = 7 | pages = 2928–36  | date = July 1997 | pmid = 9202237 | doi = 10.1210/endo.138.7.5250 | doi-access = free }}</ref>  and
+* [[SYNJ2BP]].<ref name = pmid15451561>{{cite journal | vauthors = Tsuchida K, Nakatani M, Matsuzaki T, Yamakawa N, Liu Z, Bao Y, Arai KY, Murakami T, Takehara Y, Kurisaki A, Sugino H | title = Novel factors in regulation of activin signaling | journal = Mol. Cell. Endocrinol. | volume = 225 | issue = 1–2 | pages = 1–8  | date = October 2004 | pmid = 15451561 | doi = 10.1016/j.mce.2004.02.006 | s2cid = 34666659 }}</ref><ref name = pmid11882656>{{cite journal | vauthors = Matsuzaki T, Hanai S, Kishi H, Liu Z, Bao Y, Kikuchi A, Tsuchida K, Sugino H | title = Regulation of endocytosis of activin type II receptors by a novel PDZ protein through Ral/Ral-binding protein 1-dependent pathway | journal = J. Biol. Chem. | volume = 277 | issue = 21 | pages = 19008–18  | date = May 2002 | pmid = 11882656 | doi = 10.1074/jbc.M112472200 | doi-access = free }}</ref>
+== References ==
 {{reflist}}
-==Further reading==
+==External links==
+* {{UCSC gene info|ACVR2A}}
+== Further reading ==
 {{refbegin | 2}}
+* {{cite journal | vauthors = Welt CK | title = The physiology and pathophysiology of inhibin, activin and follistatin in female reproduction | journal = Curr. Opin. Obstet. Gynecol. | volume = 14 | issue = 3 | pages = 317–23 | year = 2002 | pmid = 12032389 | doi = 10.1097/00001703-200206000-00012 | s2cid = 44327401 }}
-{{PBB_Further_reading
+* {{cite journal | vauthors = Matzuk MM, Bradley A | title = Cloning of the human activin receptor cDNA reveals high evolutionary conservation | journal = Biochim. Biophys. Acta | volume = 1130 | issue = 1 | pages = 105–8 | year = 1992 | pmid = 1311955 | doi = 10.1016/0167-4781(92)90472-C }}
-| citations =
-*{{cite journal  | author=Welt CK |title=The physiology and pathophysiology of inhibin, activin and follistatin in female reproduction. |journal=Curr. Opin. Obstet. Gynecol. |volume=14 |issue= 3 |pages= 317–23 |year= 2002 |pmid= 12032389 |doi=  }}
+* {{cite journal | vauthors = Mathews LS, Vale WW | title = Expression cloning of an activin receptor, a predicted transmembrane serine kinase | journal = Cell | volume = 65 | issue = 6 | pages = 973–82 | year = 1991 | pmid = 1646080 | doi = 10.1016/0092-8674(91)90549-E | s2cid = 36407277 }}
-*{{cite journal  | author=Matzuk MM, Bradley A |title=Cloning of the human activin receptor cDNA reveals high evolutionary conservation. |journal=Biochim. Biophys. Acta |volume=1130 |issue= 1 |pages= 105–8 |year= 1992 |pmid= 1311955 |doi=  }}
+* {{cite journal | vauthors = Xu J, McKeehan K, Matsuzaki K, McKeehan WL | title = Inhibin antagonizes inhibition of liver cell growth by activin by a dominant-negative mechanism | journal = J. Biol. Chem. | volume = 270 | issue = 11 | pages = 6308–13 | year = 1995 | pmid = 7890768 | doi = 10.1074/jbc.270.11.6308 | doi-access = free }}
-*{{cite journal  | author=Donaldson CJ, Mathews LS, Vale WW |title=Molecular cloning and binding properties of the human type II activin receptor. |journal=Biochem. Biophys. Res. Commun. |volume=184 |issue= 1 |pages= 310–6 |year= 1992 |pmid= 1314589 |doi=  }}
+* {{cite journal | vauthors = Attisano L, Cárcamo J, Ventura F, Weis FM, Massagué J, Wrana JL | title = Identification of human activin and TGF beta type I receptors that form heteromeric kinase complexes with type II receptors | journal = Cell | volume = 75 | issue = 4 | pages = 671–80 | year = 1993 | pmid = 8242742 | doi = 10.1016/0092-8674(93)90488-C | s2cid = 25408172 }}
-*{{cite journal  | author=Mathews LS, Vale WW |title=Expression cloning of an activin receptor, a predicted transmembrane serine kinase. |journal=Cell |volume=65 |issue= 6 |pages= 973–82 |year= 1991 |pmid= 1646080 |doi=  }}
+* {{cite journal | vauthors = Peng C, Huang TH, Jeung EB, Donaldson CJ, Vale WW, Leung PC | title = Expression of the type II activin receptor gene in the human placenta | journal = Endocrinology | volume = 133 | issue = 6 | pages = 3046–9 | year = 1993 | pmid = 8243335 | doi = 10.1210/endo.133.6.8243335 }}
-*{{cite journal  | author=Xu J, McKeehan K, Matsuzaki K, McKeehan WL |title=Inhibin antagonizes inhibition of liver cell growth by activin by a dominant-negative mechanism. |journal=J. Biol. Chem. |volume=270 |issue= 11 |pages= 6308–13 |year= 1995 |pmid= 7890768 |doi=  }}
+* {{cite journal | vauthors = De Winter JP, De Vries CJ, Van Achterberg TA, Ameerun RF, Feijen A, Sugino H, De Waele P, Huylebroeck D, Verschueren K, Van Den Eijden-Van Raaij AJ | title = Truncated activin type II receptors inhibit bioactivity by the formation of heteromeric complexes with activin type I. receptors | journal = Exp. Cell Res. | volume = 224 | issue = 2 | pages = 323–34 | year = 1996 | pmid = 8612709 | doi = 10.1006/excr.1996.0142 }}
-*{{cite journal  | author=Attisano L, Cárcamo J, Ventura F, ''et al.'' |title=Identification of human activin and TGF beta type I receptors that form heteromeric kinase complexes with type II receptors. |journal=Cell |volume=75 |issue= 4 |pages= 671–80 |year= 1993 |pmid= 8242742 |doi=  }}
+* {{cite journal | vauthors = Attisano L, Wrana JL, Montalvo E, Massagué J | title = Activation of signalling by the activin receptor complex | journal = Mol. Cell. Biol. | volume = 16 | issue = 3 | pages = 1066–73 | year = 1996 | pmid = 8622651 | pmc = 231089 | doi =  10.1128/mcb.16.3.1066}}
-*{{cite journal  | author=Peng C, Huang TH, Jeung EB, ''et al.'' |title=Expression of the type II activin receptor gene in the human placenta. |journal=Endocrinology |volume=133 |issue= 6 |pages= 3046–9 |year= 1994 |pmid= 8243335 |doi=  }}
+* {{cite journal | vauthors = Liu QY, Niranjan B, Gomes P, Gomm JJ, Davies D, Coombes RC, Buluwela L | title = Inhibitory effects of activin on the growth and morpholgenesis of primary and transformed mammary epithelial cells | journal = Cancer Res. | volume = 56 | issue = 5 | pages = 1155–63 | year = 1996 | pmid = 8640777 }}
-*{{cite journal  | author=De Winter JP, De Vries CJ, Van Achterberg TA, ''et al.'' |title=Truncated activin type II receptors inhibit bioactivity by the formation of heteromeric complexes with activin type I. receptors. |journal=Exp. Cell Res. |volume=224 |issue= 2 |pages= 323–34 |year= 1996 |pmid= 8612709 |doi=  }}
+* {{cite journal | vauthors = Nishitoh H, Ichijo H, Kimura M, Matsumoto T, Makishima F, Yamaguchi A, Yamashita H, Enomoto S, Miyazono K | title = Identification of type I and type II serine/threonine kinase receptors for growth/differentiation factor-5 | journal = J. Biol. Chem. | volume = 271 | issue = 35 | pages = 21345–52 | year = 1996 | pmid = 8702914 | doi = 10.1074/jbc.271.35.21345 | doi-access = free }}
-*{{cite journal  | author=Attisano L, Wrana JL, Montalvo E, Massagué J |title=Activation of signalling by the activin receptor complex. |journal=Mol. Cell. Biol. |volume=16 |issue= 3 |pages= 1066–73 |year= 1996 |pmid= 8622651 |doi=  }}
+* {{cite journal | vauthors = Lebrun JJ, Vale WW | title = Activin and inhibin have antagonistic effects on ligand-dependent heteromerization of the type I and type II activin receptors and human erythroid differentiation | journal = Mol. Cell. Biol. | volume = 17 | issue = 3 | pages = 1682–91 | year = 1997 | pmid = 9032295 | pmc = 231893 | doi =  10.1128/mcb.17.3.1682}}
-*{{cite journal  | author=Liu QY, Niranjan B, Gomes P, ''et al.'' |title=Inhibitory effects of activin on the growth and morpholgenesis of primary and transformed mammary epithelial cells. |journal=Cancer Res. |volume=56 |issue= 5 |pages= 1155–63 |year= 1996 |pmid= 8640777 |doi=  }}
+* {{cite journal | vauthors = Macías-Silva M, Hoodless PA, Tang SJ, Buchwald M, Wrana JL | title = Specific activation of Smad1 signaling pathways by the BMP7 type I receptor, ALK2 | journal = J. Biol. Chem. | volume = 273 | issue = 40 | pages = 25628–36 | year = 1998 | pmid = 9748228 | doi = 10.1074/jbc.273.40.25628 | doi-access = free }}
-*{{cite journal  | author=Nishitoh H, Ichijo H, Kimura M, ''et al.'' |title=Identification of type I and type II serine/threonine kinase receptors for growth/differentiation factor-5. |journal=J. Biol. Chem. |volume=271 |issue= 35 |pages= 21345–52 |year= 1996 |pmid= 8702914 |doi=  }}
+* {{cite journal | vauthors = Barbara NP, Wrana JL, Letarte M | title = Endoglin is an accessory protein that interacts with the signaling receptor complex of multiple members of the transforming growth factor-beta superfamily | journal = J. Biol. Chem. | volume = 274 | issue = 2 | pages = 584–94 | year = 1999 | pmid = 9872992 | doi = 10.1074/jbc.274.2.584 | doi-access = free }}
-*{{cite journal  | author=Lebrun JJ, Vale WW |title=Activin and inhibin have antagonistic effects on ligand-dependent heteromerization of the type I and type II activin receptors and human erythroid differentiation. |journal=Mol. Cell. Biol. |volume=17 |issue= 3 |pages= 1682–91 |year= 1997 |pmid= 9032295 |doi=  }}
+* {{cite journal | vauthors = Lux A, Attisano L, Marchuk DA | title = Assignment of transforming growth factor beta1 and beta3 and a third new ligand to the type I receptor ALK-1 | journal = J. Biol. Chem. | volume = 274 | issue = 15 | pages = 9984–92 | year = 1999 | pmid = 10187774 | doi = 10.1074/jbc.274.15.9984 | doi-access = free }}
-*{{cite journal  | author=Macías-Silva M, Hoodless PA, Tang SJ, ''et al.'' |title=Specific activation of Smad1 signaling pathways by the BMP7 type I receptor, ALK2. |journal=J. Biol. Chem. |volume=273 |issue= 40 |pages= 25628–36 |year= 1998 |pmid= 9748228 |doi=  }}
+* {{cite journal | vauthors = D'Abronzo FH, Swearingen B, Klibanski A, Alexander JM | title = Mutational analysis of activin/transforming growth factor-beta type I and type II receptor kinases in human pituitary tumors | journal = J. Clin. Endocrinol. Metab. | volume = 84 | issue = 5 | pages = 1716–21 | year = 1999 | doi = 10.1210/jcem.84.5.5704 | pmid = 10323406 }}
-*{{cite journal  | author=Barbara NP, Wrana JL, Letarte M |title=Endoglin is an accessory protein that interacts with the signaling receptor complex of multiple members of the transforming growth factor-beta superfamily. |journal=J. Biol. Chem. |volume=274 |issue= 2 |pages= 584–94 |year= 1999 |pmid= 9872992 |doi=  }}
+* {{cite journal | vauthors = Ebisawa T, Tada K, Kitajima I, Tojo K, Sampath TK, Kawabata M, Miyazono K, Imamura T | title = Characterization of bone morphogenetic protein-6 signaling pathways in osteoblast differentiation | journal = J. Cell Sci. | volume = 112 | issue = 20 | pages = 3519–27 | year = 1999 | doi = 10.1242/jcs.112.20.3519 | pmid = 10504300 }}
-*{{cite journal  | author=Lux A, Attisano L, Marchuk DA |title=Assignment of transforming growth factor beta1 and beta3 and a third new ligand to the type I receptor ALK-1. |journal=J. Biol. Chem. |volume=274 |issue= 15 |pages= 9984–92 |year= 1999 |pmid= 10187774 |doi=  }}
+* {{cite journal | vauthors = van Schaik RH, Wierikx CD, Timmerman MA, Oomen MH, van Weerden WM, van der Kwast TH, van Steenbrugge GJ, de Jong FH | title = Variations in activin receptor, inhibin/activin subunit and follistatin mRNAs in human prostate tumour tissues | journal = Br. J. Cancer | volume = 82 | issue = 1 | pages = 112–7 | year = 2000 | pmid = 10638976 | pmc = 2363208 | doi = 10.1054/bjoc.1999.0886 }}
-*{{cite journal  | author=D'Abronzo FH, Swearingen B, Klibanski A, Alexander JM |title=Mutational analysis of activin/transforming growth factor-beta type I and type II receptor kinases in human pituitary tumors. |journal=J. Clin. Endocrinol. Metab. |volume=84 |issue= 5 |pages= 1716–21 |year= 1999 |pmid= 10323406 |doi=  }}
+* {{cite journal | vauthors = Shoji H, Tsuchida K, Kishi H, Yamakawa N, Matsuzaki T, Liu Z, Nakamura T, Sugino H | title = Identification and characterization of a PDZ protein that interacts with activin type II receptors | journal = J. Biol. Chem. | volume = 275 | issue = 8 | pages = 5485–92 | year = 2000 | pmid = 10681527 | doi = 10.1074/jbc.275.8.5485 | doi-access = free }}
-*{{cite journal  | author=Ebisawa T, Tada K, Kitajima I, ''et al.'' |title=Characterization of bone morphogenetic protein-6 signaling pathways in osteoblast differentiation. |journal=J. Cell. Sci. |volume=112 ( Pt 20) |issue=  |pages= 3519–27 |year= 2000 |pmid= 10504300 |doi=  }}
-*{{cite journal  | author=van Schaik RH, Wierikx CD, Timmerman MA, ''et al.'' |title=Variations in activin receptor, inhibin/activin subunit and follistatin mRNAs in human prostate tumour tissues. |journal=Br. J. Cancer |volume=82 |issue= 1 |pages= 112–7 |year= 2000 |pmid= 10638976 |doi= 10.1054/bjoc.1999.0886 }}
-*{{cite journal  | author=Shoji H, Tsuchida K, Kishi H, ''et al.'' |title=Identification and characterization of a PDZ protein that interacts with activin type II receptors. |journal=J. Biol. Chem. |volume=275 |issue= 8 |pages= 5485–92 |year= 2000 |pmid= 10681527 |doi=  }}
-*{{cite journal  | author=Bondestam J, Horelli-Kuitunen N, Hildén K, ''et al.'' |title=Assignment of ACVR2 and ACVR2B the human activin receptor type II and IIB genes to chromosome bands 2q22.2-->q23.3 and 3p22 and the human follistatin gene (FST) to chromosome 5q11.2 by FISH. |journal=Cytogenet. Cell Genet. |volume=87 |issue= 3-4 |pages= 219–20 |year= 2000 |pmid= 10702675 |doi=  }}
-}}
 {{refend}}
+{{PDB Gallery|geneid=92}}
 {{TGF beta signaling}}
+{{Serine/threonine-specific protein kinases}}
-{{genetics-stub}}
+{{Enzymes}}
+{{TGFβ receptor superfamily modulators}}
+{{Portal bar|Biology|border=no}}
+{{DEFAULTSORT:Acvr2a}}
 <!--Categories-->
 [[Category:GS domain]]
 [[Category:TS domain]]
 [[Category:S/T domain]]
+[[Category:Human proteins]]
+[[Category:EC 2.7.11]]
-<!-- The PBB_Controls template provides controls for Protein Box Bot, please see Template:PBB_Controls for details. -->
-{{PBB_Controls
-| update_page = yes
-| require_manual_inspection = no
-| update_protein_box = yes
-| update_summary = yes
-| update_citations = yes
-}}

v t e Enzymes
Activity	Active site Binding site Catalytic triad Oxyanion hole Enzyme promiscuity Diffusion-limited enzyme Cofactor Enzyme catalysis
Regulation	Allosteric regulation Cooperativity Enzyme inhibitor Enzyme activator
Classification	EC number Enzyme superfamily Enzyme family List of enzymes
Kinetics	Enzyme kinetics Eadie–Hofstee diagram Hanes–Woolf plot Lineweaver–Burk plot Michaelis–Menten kinetics
Types	EC1 Oxidoreductases (list) EC2 Transferases (list) EC3 Hydrolases (list) EC4 Lyases (list) EC5 Isomerases (list) EC6 Ligases (list) EC7 Translocases (list)